During hepatocarcinogenesis, IGF-2 exerts various carcinogenic functions by binding to IGF-1 R, such as inhibiting apoptosis, promoting HCC cell proliferation and migration, and activating angiogenesis (96). Here, IGF2 is linked to hepatocellular carcinoma.